CDX-622

· Celldex Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CDX-622, covering 2026-02-23 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CDX-622 in Participants With Mild to Moderate Asthma [Phase 1]